News | Mammography | May 03, 2019

American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines

Guidelines call for early risk assessment to drive more personalized care

American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines

May 3, 2019 — The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a patient’s individual breast cancer risk profile, with clear, specific strategies for screening management.

“Our members are on the front lines with breast cancer patients every day, guiding them through all stages of breast cancer diagnosis and treatment. These new recommendations were ASBrS member-driven and developed based on their unique, firsthand perspective on the disease and patient journey. They represent a deep, passionate and scientifically backed commitment to advocate for increased years of life over costs,” said Shawna Willey, M.D., FACS, ASBrS chairman of the board and professor of clinical surgery, director, MedStar Regional Breast Health Program, chief of surgery, MedStar Georgetown University Hospital, Washington, D.C. “They also aim to minimize breast cancer disparities across race and ethnicity through earlier disease detection for all.”

The new recommendations differ from current U.S. Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) guidelines. Those guidelines apply only to women with average risk and also factor in screening costs per diagnosis and related issues along with mortality, but are supported by the American College of Radiology (ACR).

Drawing on the strongest body of currently available research on the impact of breast cancer screening, the guidelines recommend that all women undergo formal risk assessment by age 25. For women with average risk, they recommend annual screening starting at age 40. For women with increased likelihood of developing the disease, they call for a range of more comprehensive screening strategies based on specific risk factors.

For example, for those with a predicted breast cancer lifetime risk of ≥ 20 percent, they call for mammography and access to supplemental magnetic resonance imaging (MRI) starting at age 35. For women with breast cancer-related genetic abnormalities, they call for similar imaging starting at age 25.

“Routine screening for women age 40 to 49 has been unequivocally demonstrated to reduce mortality by 15 percent. However, today USPSTF guidelines delay annual screening until age 50 because they are based on an efficiency statistical model that also considers the impact of potential screening risks,” noted Walton A. Taylor, M.D., FACS, ASBrS president and Texas Health Physicians Group, Dallas. “In addition to elevated costs, these include a statistical probability of false negative and positive results leading to unnecessary anxiety and additional medical procedures, overdiagnosis of indolent cancers and increased radiation exposure.”

“ASBrS guidelines are based on a life-years gained model,” noted Julie Margenthaler, M.D., FACS, director of breast surgical services of the Joanne Knight Breast Center at Siteman Cancer Center, professor of surgery, Washington University School of Medicine, St. Louis. “They are based solely on the demonstrated breast cancer survival benefits. The ASBrS prioritizes life. Members put this priority to work every day when treating patients. We believe women should have an opportunity to choose earlier screening if potentially beneficial. Additionally, our understanding of breast cancer risks and risk assessment has advanced. Managing screening based on those risks is an important part of today’s personalized medicine.”

Margenthaler added, “While mammographic screening is not as easy or accurate in younger women, when we find and treat cancer, the benefits in years of life saved are highly significant. Many current guidelines will leave a subset of these women to die.”

In addition to formal breast cancer risk assessment for every woman, the new ASBrS recommendations contain many components distinguishing them from other existing academic and professional organization guidelines. These include the detailed stratification of risk, the specificity of actionable recommendations for each group, and suggestions for patient discussion and shared decision-making. The new ASBrS guidelines also take into account specific breast cancer sub-types more common among certain racial and ethnic groups. They suggest enhanced surveillance leading to earlier diagnosis and treatment in an effort to achieve healthcare equality.

While most health insurers will cover some recommended strategies such as risk assessment and 3-D mammograms before age 50, the ASBrS specifically did not restrict guidelines to currently covered procedures. “We want to be change agents on behalf of our patients and hope that these guidelines will encourage insurers to rethink some of their coverage policies,” noted Taylor.

“The ACR supports the American Society of Breast Surgeons recommendations that women start getting annual mammograms at age 40. The American Cancer Society, U.S. Preventive Services Task Force, ACR and the Society of Breast Imaging agree that the most lives are saved by this approach. Catching more cancers early by starting yearly screening at age 40 – rather than less frequent or later screening – increases the odds of successful treatment and can preserve quality of life for women. We are pleased that ASBrS has reaffirmed their support for this most sensible approach,” said Dana Smetherman, M.D., chair of the American College of Radiology Commission on Breast Imaging.

The new ASBrS guidelines and screening mammography position statement were developed by an ASBrS panel, co-chaired by Willey and Pat Whitworth, M.D., FACS, director, Nashville Breast Center.

Read the full guidelines here.

For more information: www.breastsurgeons.org

Related Content

Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

News | Coronavirus (COVID-19) | May 06, 2020
May 6, 2020 — The COVID-19 pandemic is an unprec
The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) of the American College of Surgeons, and the American College of Radiology (ACR) have released new joint recommendations for prioritization, treatment and triage of breast cancer patients during the coronavirus (COVID-19) pandemic

Getty Images

News | Breast Imaging | April 13, 2020
April 13, 2020 — The American Society of Breast Surgeons (...
Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Sponsored Content | Case Study | Artificial Intelligence | April 09, 2020
As the largest independent imaging group in Michigan with 10 locations across the state,...